J&J expects double-digit 2023 profit growth after Kenvue spinoff
(Reuters) -Johnson & Johnson on Wednesday forecast double-digit profit growth for 2023 after spinning off...
N2:PHAG08
N2:ACB
N2:CMPNY
N2:DEAL1
N2:EUROP
N2:HEA
N2:IE
N2:INSR
N2:JUDIC
N2:MONOP
N2:MRG
N2:NAMER
N2:NEWS1
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBL
N2:REGS
N2:US
N2:WASH
US FTC suspends challenge to block Amgen’s $27.8 billion deal for Horizon Therapeutics
(Reuters) -The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen’s $27.8 billion...
US FDA puts Gilead Sciences blood cancer drug studies on hold
(Reuters) -Gilead Sciences said on Monday the U.S. health regulator placed a clinical hold on...
Gilead quarterly profit falls on COVID sales drop, legal settlement charge
By Michael Erman (Reuters) -Gilead Sciences on Thursday reported lower second-quarter profit as costs from...
N2:BLR
N2:CMPNY
N2:CPROD
N2:DRUDEV
N2:HEA
N2:HEADMI
N2:HECA
N2:MRCH
N2:MTPIX
N2:NAMER
N2:PHAG08
N2:PHAR
N2:PHAR1
N2:PHMR
N2:PUBL
N2:PXP
N2:RES
N2:RESF
N2:RHEUMA
N2:SCI
N2:TOPNWS
N2:US
AbbVie trims forecast for Humira sales drop on favorable coverage
By Leroy Leo and Patrick Wingrove (Reuters) -AbbVie on Thursday trimmed its 2023 view for...
N2:BLR
N2:CMPNY
N2:DVST
N2:IPO
N2:MTPIX
N2:NAMER
N2:PHAG08
N2:PHAR1
N2:PSNPR
N2:PSNPR1
N2:PUBL
N2:PXP
N2:TOPNWS
N2:US
J&J starts share exchange offer for consumer health spin-off Kenvue
(Reuters) -Johnson & Johnson said on Monday it had launched an exchange offer under which...
N2:BLR
N2:CMPNY
N2:COVID
N2:DRUGEN
N2:HEA
N2:HECA
N2:MEDDTE
N2:MEDQ
N2:MEDQ1
N2:MRCH
N2:MTPIX
N2:NAMER
N2:NEWS1
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBL
N2:PXP
N2:RES
N2:RESF
N2:US
N2:VACCIN
J&J upbeat on 2023 as devices rebound post-COVID, shares jump
By Bhanvi Satija and Patrick Wingrove (Reuters) -Johnson & Johnson on Thursday expressed optimism for...
US FTC seeks additional info on Pfizer’s proposed takeover of Seagen
(Reuters) -The US Federal Trade Commission (FTC) has sought additional information and documentary material related...
N2:BKRT
N2:CASE1
N2:CLASS
N2:CMPNY
N2:CNCER
N2:CONG08
N2:DBTR
N2:HEA
N2:HECA
N2:JUDIC
N2:MTPIX
N2:NAMER
N2:PHAG08
N2:PHAR1
N2:PUBL
N2:US
N2:USACA
Jurors urged to impose heavy punitive damages in J&J talc trial
By Brendan Pierson (Reuters) – Lawyers for a California man who says he developed a...
N2:ASIA
N2:BIOPH
N2:CMPNY
N2:CPROD
N2:DEMENT
N2:DRUDEV
N2:HEA
N2:HEADMI
N2:INSR
N2:JP
N2:MEDREG
N2:MRCH
N2:MTGFX
N2:MTPIX
N2:NAMER
N2:NEWS1
N2:PHAG08
N2:PHAR1
N2:PHMR
N2:PUBL
N2:SCI
N2:TOPNWS
N2:US
US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -Eisai and Biogen’s Leqembi won a...